Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling of Deviations

Posted on By

SOP for Handling of Deviations

Standard Operating Procedure for Handling of Deviations

1) Purpose

The purpose of this SOP is to establish procedures for handling and investigating deviations from established processes, procedures, and specifications to ensure product quality and compliance.

2) Scope

This SOP applies to all deviations identified within the manufacturing facility that may impact product quality, safety, or efficacy.

3) Responsibilities

The responsibilities for this SOP are divided among various roles:

3.1 Production Supervisor:

Responsible for documenting and reporting deviations to the Quality Assurance (QA) department.

3.2 Quality Assurance (QA) Personnel:

Responsible for investigating deviations, determining root causes, and implementing corrective actions.

See also  SOP for Product Complaint Handling

3.3 Department Managers:

Responsible for implementing corrective actions and preventing recurrence of deviations within their departments.

4) Procedure

4.1 Identification and Documentation of Deviations:

4.1.1 Identify and document deviations from established processes, procedures, or specifications.
4.1.2 Record deviations in the Deviation Report Form.
4.1.3 Notify QA and relevant personnel of identified deviations.

4.2 Investigation of Deviations:

4.2.1 QA personnel must initiate an investigation into the deviation.
4.2.2 Gather information, conduct interviews, and review documentation to determine the root cause.
4.2.3 Document investigation findings and proposed corrective actions.

4.3 Evaluation and Risk Assessment:

4.3.1 Assess the impact of the deviation on product quality, safety, and efficacy.
4.3.2 Determine the risk associated with the deviation using risk assessment

tools.
4.3.3 Classify the deviation based on severity and potential impact.

See also  Rectal Dosage Forms: SOP for Internal Audits

4.4 Implementation of Corrective Actions:

4.4.1 Develop and implement corrective actions to address the root cause of the deviation.
4.4.2 Implement preventive actions to prevent recurrence of similar deviations.
4.4.3 Obtain approval for corrective and preventive actions from QA.

4.5 Documentation and Review:

4.5.1 Document all steps of the deviation handling process, including identification, investigation, risk assessment, and corrective actions.
4.5.2 Review deviation records regularly to ensure compliance with procedures and effectiveness of corrective actions.
4.5.3 Archive deviation records according to established document retention policies.

5) Abbreviations, if any

QA – Quality Assurance

6) Documents, if any

1. Deviation Report Form
2. Investigation Findings
3. Corrective and Preventive Action (CAPA) Plans
4. Deviation Log

See also  Rectal Dosage Forms: SOP for Change Control Management

7) Reference, if any

1. FDA Guidance on Investigating Out-of-Specification (OOS) Results
2. ICH Q10 Pharmaceutical Quality System

8) SOP Version

Version 1.0

Rectal Dosage Forms Tags:Enema preparation guidelines, GMP for rectal products, Rectal administration SOP, Rectal dosage batch record keeping, Rectal dosage change control procedure, Rectal dosage cleaning validation, Rectal dosage emergency response SOP, Rectal dosage environmental monitoring SOP, Rectal dosage facility sanitation SOP, Rectal dosage form stability testing SOP, Rectal dosage forms SOP, Rectal dosage GMP guidelines, Rectal dosage incident investigation procedure, Rectal dosage manufacturing procedures, Rectal dosage raw material handling SOP Rectal dosage equipment maintenance SOP, Rectal dosage risk management plan, Rectal dosage SOP templates, Rectal dosage sterilization SOP, Rectal dosage supplier qualification SOP, Rectal dosage testing procedures, Rectal drug delivery systems SOP, Rectal drug formulation SOP, Rectal enema preparation SOP, Rectal medication packaging SOP, Rectal product contamination control SOP, Rectal product documentation management, Rectal product inspection SOP, Rectal product labeling SOP, Rectal product quality control SOP, Rectal product storage SOP, Rectal suppository manufacturing guidelines, Suppository manufacturing SOP

Post navigation

Previous Post: SOP for Hygroscopicity Testing in Powders
Next Post: Vaginal Dosage Forms: SOP for Finished Product Sampling

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version